Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture

References

• Almarsson Ö, Zaworotko MJ. (2004). Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Chem Commun (Camb), 17:1889–1896.
   PubMed Web of Science ®Google Scholar
• McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS et al. (2006). Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res, 23:1888–1897.
   PubMed Web of Science ®Google Scholar
• Karki S, Friščić T, Fábián L, Laity PR, Day GM, Jones W. (2009). Improving mechanical properties of crystalline solids by cocrystal formation: New compressible forms of paracetamol. Adv Mater, 21:3905–3509.
   Web of Science ®Google Scholar
• Shan N, Zaworotko MJ. (2008). The role of cocrystals in pharmaceutical science. Drug Discov Today, 13:440–446.
   PubMed Web of Science ®Google Scholar
• Blagden N, de Matas M, Gavan PT, York P. (2007). Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev, 59:617–630.
   PubMed Web of Science ®Google Scholar
• Yadav AV, Dabke AP, Shete AS. (2010). Crystal engineering to improve physicochemical properties of mefloquine hydrochloride. Drug Dev Ind Pharm, 36:1036–1045.
   PubMed Web of Science ®Google Scholar
• Chow K, Tong HH, Lum S, Chow AH. (2008). Engineering of pharmaceutical materials: An industrial perspective. J Pharm Sci, 97:2855–2877.
   PubMed Web of Science ®Google Scholar
• Vippagunta SR, Brittain HG, Grant DJ. (2001). Crystalline solids. Adv Drug Deliv Rev, 48:3–26.
   PubMed Web of Science ®Google Scholar
• Tantry JS, Tank J, Suryanarayanan R. (2007). Processing-induced phase transitions of theophylline–implications on the dissolution of theophylline tablets. J Pharm Sci, 96:1434–1444.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res, 14:1691–1698.
   PubMed Web of Science ®Google Scholar
• York P. (1983). Solid-state properties of powders in the formulation and processing of solid dosage forms. Int J Pharm, 14:1–28.
   Web of Science ®Google Scholar
• Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG. (2001). Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev, 48:91–114.
   PubMed Web of Science ®Google Scholar
• Good DJ, Rodríguez-Hornedo N. (2009). Solubility advantage of pharmaceutical cocrystals. Cryst Growth Des, 9:2252–2264.
   Web of Science ®Google Scholar
• Jayasankar A, Roy L, Rodríguez-Hornedo N. (2010). Transformation pathways of cocrystal hydrates when coformer modulates water activity. J Pharm Sci, 99:3977–3985.
   PubMed Web of Science ®Google Scholar
• Basavoju S, Boström D, Velaga SP. (2008). Indomethacin-saccharin cocrystal: Design, synthesis and preliminary pharmaceutical characterization. Pharm Res, 25:530–541.
   PubMed Web of Science ®Google Scholar
• Reddy LS, Bhatt PM, Banerjee R, Nangia A, Kruger GJ. (2007). Variable-temperature powder X-ray diffraction of aromatic carboxylic acid and carboxamide cocrystals. Chem Asian J, 2:505–513.
   PubMed Web of Science ®Google Scholar
• Heinz A, Savolainen M, Rades T, Strachan CJ. (2007). Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy. Eur J Pharm Sci, 32:182–192.
   PubMed Web of Science ®Google Scholar
• Chieng N, Rehder S, Saville D, Rades T, Aaltonen J. (2009). Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction. J Pharm Biomed Anal, 49:18–25.
   PubMed Web of Science ®Google Scholar
• Tiwari M, Chawla G, Bansal AK. (2007). Quantification of olanzapine polymorphs using powder X-ray diffraction technique. J Pharm Biomed Anal, 43:865–872.
   PubMed Web of Science ®Google Scholar
• Agatonovic-Kustrin S, Wu V, Rades T, Saville D, Tucker IG. (1999). Powder diffractometric assay of two polymorphic forms of ranitidine hydrochloride. Int J Pharm, 184:107–114.
   PubMed Web of Science ®Google Scholar
• Campbell Roberts SN, Williams AC, Grimsey IM, Booth SW. (2002). Quantitative analysis of mannitol polymorphs. X-ray powder diffractometry–exploring preferred orientation effects. J Pharm Biomed Anal, 28:1149–1159.
   PubMed Web of Science ®Google Scholar
• Surana R, Suryanarayanan R. (2000). Quantitation of crystallinity in substantially amorphous pharmaceuticals and study of crystallization kinetics by X-ray powder diffractometry. Powder Diff, 15:2–6.
   Web of Science ®Google Scholar
• Fix I, Steffens KJ. (2004). Quantifying low amorphous or crystalline amounts of α-lactose-monohydrate using X-ray powder diffraction, near-infrared spectroscopy, and differential scanning calorimetry. Drug Dev Ind Pharm, 30:513–523.
   PubMed Web of Science ®Google Scholar
• Hurst VJ, Schroeder PA, Styron RW. (1997). Accurate quantification of quartz and other phases by powder X-ray diffractometry. Anal Chim Acta, 337:233–252.
   Web of Science ®Google Scholar
• Alam S, Patel S, Bansal AK. (2010). Effect of sample preparation method on quantification of polymorphs using PXRD. Pharm Dev Technol, 15:452–459.
   PubMed Web of Science ®Google Scholar
• Tian F, Zhang F, Sandler N, Gordon KC, McGoverin CM, Strachan CJ et al. (2007). Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy. Eur J Pharm Biopharm, 66:466–474.
   PubMed Web of Science ®Google Scholar
• Jung MS, Kim JS, Kim MS, Alhalaweh A, Cho W, Hwang SJ et al. (2010). Bioavailability of indomethacin-saccharin cocrystals. J Pharm Pharmacol, 62:1560–1568.
   PubMed Web of Science ®Google Scholar
• Kojima T, Tsutsumi S, Yamamoto K, Ikeda Y, Moriwaki T. (2010). High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate. Int J Pharm, 399:52–59.
   PubMed Web of Science ®Google Scholar
• Umeda Y, Fukami T, Furuishi T, Suzuki T, Tanjoh K, Tomono K. (2009). Characterization of multicomponent crystal formed between indomethacin and lidocaine. Drug Dev Ind Pharm, 35:843–851.
   PubMed Web of Science ®Google Scholar
• Mohammad MA, Alhalaweh A, Velaga SP. (2011). Hansen solubility parameter as a tool to predict cocrystal formation. Int J Pharm, 407:63–71.
   PubMed Web of Science ®Google Scholar
• Padrela L, Rodrigues MA, Velaga SP, Matos HA, de Azevedo EG. (2009). Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. Eur J Pharm Sci, 38:9–17.
   PubMed Web of Science ®Google Scholar
• Clas S-D, Faizer R, O’Conner RE. (1995). Quantification of crystallinity in blends of lyophilized and crystalline MK-0591 using X-ray powder diffraction. Int J Pharm, 121:73–79.
   Web of Science ®Google Scholar
• International Conference on Harmonization (ICH) Harmonized Tripartite Guideline, Note for guidance on validation of analytical procedures: Methodology, CPMP/ICH/281/95, 1996.
   Google Scholar
• Bugay DE, Newman AW, Findlay WP. (1996). Quantitation of cefepime.2HCl dihydrate in cefepime.2HCl monohydrate by diffuse reflectance IR and powder X-ray diffraction techniques. J Pharm Biomed Anal, 15:49–61.
   PubMed Web of Science ®Google Scholar
• Friščić T, Childs SL, Rizvi SAA, Jones W. (2009). The role of solvent in mechanochemical and sonochemical cocrystal formation: A solubility-based approach for predicting cocrystallisation outcome. Cryst Eng Comm, 11:418–426.
   Google Scholar